– Novavax está preparado para entregar la vacuna XBB COVID monovalente a base de proteínas de acuerdo con la recomendación VRBPAC de la FDA para el otoño Novavax ha desarrollado una candidata a vacuna contra la COVID XBB.1.5 monovalente a base de proteínas y se está fabricando a escala…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.